President Trump signed the bill into law, included in Sec. 210. Promoting access to life-saving therapies for Medicaid enrollees by ensuring coverage of routine patient costs for items and services furnished in connection with participation
in qualifying clinical trials. The bill has now successfully become law.

The bill passed the Senate as a part of the Fiscal Year 2021 budget package and COVID-19 response bill.

The bill passed the House as a part of the Fiscal Year 2021 budget package and a COVID-19 response bill. The specific provision is on page 4737 of the bill.

AACI is featured on a community endorsement letter, spearheaded by the Association for Clinical Oncology (ASCO) thanking Senators Burr and Cardin for introducing the bill in the Senate.

Senator Richard Burr (R-NC) and Senator Ben Cardin (D-MD)announced the introduction of a Senate version of the CLINICAL Treatment Act.

The Cancer Letter publishes an article about the efforts of a coalition of over 100 cancer groups, including AACI, urging Congress to include the CLINICAL TREATMENT Act in an upcoming health care extenders package. Coalition of cancer groups urges Congress to include clinical trial-related coverage under Medicaid

AACI urges its members in an August 2019 AACI Update story to write to their congressional delegation in support of the CLINICAL TREATMENT Act.

AACI is featured on a community endorsement letter, spearheaded by the Association for Clinical Oncology (ASCO), in support of H.R. 913, the CLINICAL TREATMENT Act. Learn more about ASCO's efforts.

Introduced in House of Representatives and referred to House Committee on Energy and Commerce